1. To be presented at US Pharmacopeial Forum 39(5) Oct 2013 for inclusion into USP, section <771>, Ophthalmic Preparations–Quality Tests
2. Edelhauser HF, Rowe-Rendleman C-L, Robinson MR, Dawson DG, Chader GJ, Grossniklaus HE, Rittenhouse KD, Wilson CG, Weber DA, Kuppermann BD, Csaky KG, Olsen TW, Kompella UB, Holers VM, Hageman GS, Gilger BC, Campochiaro PA, Whitcup SM, Wong WT (2010) Ophthalmic drug delivery systems for the treatment of retinal diseases: basic research to clinical applications. IOVS 51(11):5403–5020. doi:10.1167/IOVS.10-5392
3. Lang JC (1995) Ocular drug delivery conventional ocular formulations. Adv Drug Deliv Rev 16:39–43
4. Yu LX (2008) Pharmaceutical quality by design: product and process development, understanding and control. Pharm Res 25(4):781–791
5. Urtti A (2006) Challenges and obstacles of ocular pharmacokinetics and drug delivery. Adv Drug Deliv Rev 58:1131–1135